Insiders · Profile

Fridriksdottir Hafrun

Executive VP, Global R&D at TEVA PHARMACEUTICAL INDUSTRIES. Filing since 19 Mar 2018. CIK 0001561458

Company
Date
Role
Action
Shares
Amount
Of holding
17 May 2022
Executive VP, Global R&D
Sold, plan not stated
130,000
$1.07M
98.9%
7 Mar 2022
Executive VP, Global R&D
Sold, plan not stated
8,941
$65.87K
6.6%
4 Mar 2022
Executive VP, Global R&D
Sold, plan not stated
24,638
$184.35K
19.9%
28 Feb 2022
Executive VP, Global R&D
Sold, plan not stated
7,590
$61.80K
10.4%
9 Feb 2022
Executive VP, Global R&D
Sold, plan not stated
6,116
$55.41K
10.6%
10 Aug 2021
Executive VP, Global R&D
Sold, plan not stated
50,860
$506.02K
55.1%
11 May 2021
Executive VP, Global R&D
Sold, plan not stated
19,066
$194.83K
17.1%
4 Mar 2021
Executive VP, Global R&D
Sold, plan not stated
9,515
$100.54K
11.5%
2 Mar 2021
Executive VP, Global R&D
Sold, plan not stated
50,000
$540.89K
43.8%
1 Mar 2021
Executive VP, Global R&D
Sold, plan not stated
10,912
$118.19K
8.7%
16 Feb 2021
Executive VP, Global R&D
Sold, plan not stated
2,098
$23.34K
2.0%
9 Feb 2021
Executive VP, Global R&D
Sold, plan not stated
29,496
$374.44K
22.8%
17 Mar 2020
Executive VP, Global R&D
Sold, plan not stated
514
$3.68K
1.1%
14 Feb 2020
Executive VP, Global R&D
Sold, plan not stated
11,472
$139.30K
20.3%
10 Feb 2020
Executive VP, Global R&D
Sold, plan not stated
5,544
$68.02K
14.3%
31 Dec 2019
Executive VP, Global R&D
Sold, plan not stated
2,459
$24.40K
9.8%
2 Dec 2019
Executive VP, Global R&D
Sold, plan not stated
4,310
$45.21K
17.3%
18 Mar 2019
Executive VP, Global R&D
Sold, plan not stated
356
$5.92K
2.1%
4 Mar 2019
Executive VP, Global R&D
Sold, plan not stated
409
$6.91K
2.5%
14 Feb 2019
Executive VP, Global R&D
Sold, plan not stated
1,841
$32.53K
10.7%
2 Jan 2019
Executive VP, Global R&D
Sold, plan not stated
1,643
$25.80K
12.2%
30 Nov 2018
Executive VP, Global R&D
Sold, plan not stated
933
$20.30K
9.6%
19 Mar 2018
Executive VP, Global R&D
Sold, plan not stated
348
$6.22K
4.7%
23 decisions on file.